The Clinical Development Team at Byondis is responsible for the design, execution, and oversight of clinical trials to evaluate the safety and efficacy of Byondis' novel treatments. This team works closely with regulatory bodies, research organizations, and healthcare professionals to ensure that clinical trials adhere to all regulatory requirements and achieve the highest quality standards. They play a crucial role in translating Byondis' innovative molecular concepts, such as next-generation antibody-drug conjugates and monoclonal antibodies, into viable therapeutic options for patients with high unmet medical needs.